Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ascrinvacumab by Kintor Pharmaceutical for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC). According to...
Data Insights
Ascrinvacumab by Kintor Pharmaceutical for Liver Cancer: Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase I for Liver Cancer. According to GlobalData, Phase...